Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05609097 · ClinicalTrials.gov registry record · NA

PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction

A NA study of Heart Failure With Reduced Ejection Fraction, sponsored by University of Virginia.

Recruiting
Registry status
NA
Development phase
92
Enrollment target
1
Study location

NCT05609097 is a NA study of Heart Failure With Reduced Ejection Fraction that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 92 participants, below the 3,962-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05609097, a NA study of Heart Failure With Reduced Ejection Fraction, is actively recruiting participants, sponsored by University of Virginia.

RECRUITING
Registry status
NA
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

This study is trying to find out whether performing a hybrid aerobic-resistance exercise training program (titled PRIME: Peripheral Remodeling via Intermittent Muscular Exercise) results in better health outcomes than the traditional exercise training program (called COMBO) that is used in individuals with heart failure with reduced ejection fraction (HFrEF). Participants will be randomized (like the flip of a coin) to either PRIME (investigational) or the traditional exercise program (standard of care).

Conditions Studied

Heart Failure With Reduced Ejection Fraction

Interventions

  • OTHER PRIME
  • OTHER COMBO

Study Locations (1)

Virginia

  • University of Virginia, Department of Kinesiology - Charlottesville

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2023-04-14
Est. Completion 2028-06-30
Phase NA

Sponsor

University of Virginia

449 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05609097

The ClinicalTrials.gov registry entry for NCT05609097 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,962-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (98% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure With Reduced Ejection Fraction appearing as the primary indexed condition, and to 2 interventions - of which PRIME is the first listed.

NCT05609097 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05609097 about?

NCT05609097 is a clinical study titled "PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction". This study is trying to find out whether performing a hybrid aerobic-resistance exercise training program (titled PRIME: Peripheral Remodeling via Intermittent Muscular Exercise) results in better health outcomes than the traditional exercise training program (called COMBO) that is used in individua...

What is the current status of trial NCT05609097?

This trial is currently recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2023-04-14. Estimated completion is 2028-06-30.

What conditions does trial NCT05609097 study?

This clinical trial studies the following conditions: Heart Failure With Reduced Ejection Fraction.

What interventions are being tested in trial NCT05609097?

The interventions under investigation include: PRIME (OTHER), COMBO (OTHER).

Who is sponsoring clinical trial NCT05609097?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05609097 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure With Reduced Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure With Reduced Ejection Fraction

All registered trials for this condition

Virginia

All trials with a study site in Virginia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.